Assisted NC businesses in winning 3,168 contracts minimum value of $10.3 billion

2019 MBB Session Summaries

Defense and Military Medical Requirements: Research, Development, and Acquisition Processes.  Panel presenters will provide overviews of the Defense Health Program (DHP) and the overall military medical research and development enterprise.  They will describe the roles and relationships of the Office of the Assistant Secretary of Defense for Health Affairs (OASD(HA)), the Defense Health Agency (DHA), and the U.S. Army Medical Research and Materiel Command (USAMRMC) and its subordinate organizations, including the U.S. Army Medical Materiel Development Activity (USAMMDA) and the U.S. Army Medical Research Acquisition Activity (USAMRAA).  The presenters will also discuss the Congressionally Directed Medical Research Programs (CDMRP), the six core DHP research program areas, and their execution management support by the Joint Program Committees (JPCs). 

Requirements and Acquisitions Processes: Department of Veterans Affairs & North Carolina Veterans Affairs Facilities: Panel presenters will identify requirements of VA medical centers and clinics in the region for medical products and services, including research and development, supplies, equipment, devices, pharmaceuticals, training, IT and staff augmentation.  They will also outline the processes they use to acquire these products and services, including use of prime vendors, GSA schedules, Governmentwide Acquisition Contracts (GWACs) and commercial contracts.  Businesses and researchers with the capability to support VA medical centers and clinics, vendors or other businesses with medical products or services should participate in this session.

  • Ruby Harvey, Executive Director, Office of Small Disadvantaged Business Utilization, US Department of Veterans Affairs
  • Joseph Vaughn, Director, Salisbury Veterans Affairs Medical Center

Biodefense Research and Development: Interagency Priorities and Perspectives.  Panel presenters will provide overviews of key federal biodefense research and development organizations and mission areas, a focus on the Departments of Defense (DoD) and Health and Human Services (HHS).  Representatives from the Defense Threat Reduction Agency (DTRA) and the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) will cover DoD biodefense research, development, and acquisition programs.  Representatives from the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA) will describe their roles in the development and transition of medical countermeasures against biological threats and emerging infectious diseases.

  • Christopher Houchens, Ph.D., Branch Chief, Antibacterials Program, Biomedical Advanced Research and Development Authority, US Department of Health and Human Services

Requirements and Acquisition Processes: Military Medical Facilities and Operational Medical Commands: Panel presenters will identify requirements of military hospitals, clinics and operational medical commands (conventional forces) in North Carolina for medical products and services, including research and development, supplies, equipment, devices, pharmaceuticals, training, IT and staff augmentation. They will also outline the processes they use to acquire these products and services, including Defense Logistics Agency prime vendors, GSA schedules, Governmentwide Acquisition Contracts (GWACs), commercial contracts and the military Class VIII supply system. Businesses with the capability to support installation medical facilities, deployable medical units, DLA prime vendors or other contractors with products or services should participate in this session. 

  • Captain Jeffrey Timby, Commander, Naval Medical Center Camp Lejeune
  • Colonel John Melton, Commander, Womack Army Medical Center

Defense R&D Funding and Support Mechanisms.  Panel presenters will provide insights on federal mechanisms to engage the extramural community in sponsored research and development activities.  They will cover common solicitation and funding processes for agency-specific R&D programs, including Broad Agency Announcements (BAAs) and the Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs.  This session will also offer an overview of newer federal funding models and instruments that have been developed through Other Transaction Authorities (OTAs), as streamlined pathways to accelerate the advancement of research and technology innovations.      

Acquisition and Teaming Processes: Department of Defense and Department of Veterans Affairs Prime Vendors:  Prime vendors to the Department of Defense (including Defense Logistics Agency), Department of Veterans Affairs and Department of Health and Human Services will provide remarks on experiences and realities of doing business with the government agencies.  They will discuss the agencies respective medical prime vendor systems, their experiences in doing businesses with these agencies and their process for leveraging subcontractors (including utilization of DLA Distribution and Pricing Registration Agreement [DAPA] holders) and their SDVOSB partners.  North Carolina product providers and manufacturers will also provide remarks regarding their experiences in supplying the Department of Defense and other federal agencies.

  • Samantha Godfrey, President and CEO, United Drug Supply, Inc. WOSB
  • Stephen Flannery, United Drug Supply, Inc. WOSB
  • Wendy Burns, Senior Director Materials Management, American Medical Depot (AMD)
  • Richard Webb, Director, Government Accounts, Owens & Minor
  • Zach Decker, Government Operations Manager, Owens & Minor
  • Corey Russ, CEO, Combat Medical 

Public-Private Partnerships: Research and Development Consortia and Accelerators.  Panel presenters will share information on the use of public-private partnerships as models for stimulating innovation through sponsored research and development.  They will provide overviews of several partnership-enabled consortia and accelerators, including BARDA’s new Division of Research, Innovation, and Ventures (DRIVe) and their participation in the partnership, Combating Antibiotic Resistant Bacteria (CARB-X), and, as well as DoD’s Medical CBRN Defense Consortium (MCDC) and Medical Technology Enterprise Consortium (MTEC).  Presenters will discuss their organization’s background and structure, as well as their unique mechanisms for engaging the research community to solve significant public health and biomedical challenges.

  • Tyler Merkely, Director of the Division of Research, Innovation and Ventures (DRIVe), Biomedical Advanced Research and Development Authority (BARDA), US Department of Health and Human Services
  • Kevin Outterson, J.D., L.L.M, Executive Director, CARB-X and Professor of Law & N. Neal Pike Scholar in Health and Disability Law, Boston University




The NC Military Business Center, the NC Community College System, and the State of North Carolina do not officially endorse events. These items are posted strictly for the information and convenience of NCMBC customers.

website by Biz Tools One